FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37314355> ?p ?o ?g. }

• Q37314355 description "article científic" @default.
• Q37314355 description "article scientifique" @default.
• Q37314355 description "articolo scientifico" @default.
• Q37314355 description "artigo científico" @default.
• Q37314355 description "artículu científicu espublizáu en 2013" @default.
• Q37314355 description "bilimsel makale" @default.
• Q37314355 description "scientific article published on December 2013" @default.
• Q37314355 description "vedecký článok" @default.
• Q37314355 description "vetenskaplig artikel" @default.
• Q37314355 description "videnskabelig artikel" @default.
• Q37314355 description "vědecký článek" @default.
• Q37314355 description "wetenschappelijk artikel" @default.
• Q37314355 description "wissenschaftlicher Artikel" @default.
• Q37314355 description "наукова стаття, опублікована в грудні 2013" @default.
• Q37314355 description "научни чланак" @default.
• Q37314355 description "مقالة علمية نشرت في ديسمبر 2013" @default.
• Q37314355 name "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 name "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 name "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 type Item @default.
• Q37314355 label "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 label "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 label "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 prefLabel "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 prefLabel "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 prefLabel "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 P1433 Q37314355-6DA5688F-A80E-4890-A967-267F0E00C2B0 @default.
• Q37314355 P1476 Q37314355-E604A826-2D14-40E2-94C0-E2F13AB6B44E @default.
• Q37314355 P2093 Q37314355-0E934102-0278-484F-A42C-E9162615D8C7 @default.
• Q37314355 P2093 Q37314355-1411FDED-BBF1-4530-80B1-6FAC8BFCB3F8 @default.
• Q37314355 P2093 Q37314355-2EF519D4-DEB7-49C7-8E0B-41B1C1601564 @default.
• Q37314355 P2093 Q37314355-3E219BFA-A619-4BFC-8061-9E7DC569D85C @default.
• Q37314355 P2093 Q37314355-71AA3FC3-4494-4B38-ACA6-B047A006BD46 @default.
• Q37314355 P2093 Q37314355-8BCF180A-4FC4-4B38-B11D-2716A1EADD99 @default.
• Q37314355 P2093 Q37314355-8D8E6C1C-1F6D-430D-91AF-C001F5F00F6B @default.
• Q37314355 P2093 Q37314355-922E86DC-9604-46BB-A4E7-14719C212E55 @default.
• Q37314355 P2093 Q37314355-A56DEA86-225A-4CC5-A7BB-514DDE87919E @default.
• Q37314355 P2093 Q37314355-B0D5FE1E-6942-4C2E-9041-13EEB50AF6BF @default.
• Q37314355 P2093 Q37314355-BFB616D1-B4BF-4F33-BE3E-21D2B0560A1F @default.
• Q37314355 P2093 Q37314355-F6AE8523-1F1D-4A4C-86A3-B21579DD00C7 @default.
• Q37314355 P275 Q37314355-b2d40aaf-2b32-4c25-93c5-31adb251d9ac @default.
• Q37314355 P2860 Q37314355-02DE40D7-8B93-42A6-A7FF-C807DB57351E @default.
• Q37314355 P2860 Q37314355-03077ED2-9E8F-4E6B-AF1B-257F3E5652E5 @default.
• Q37314355 P2860 Q37314355-25E8A3B2-B43B-4EDA-A450-F57BF72E170F @default.
• Q37314355 P2860 Q37314355-28C08B45-19C2-4B23-98BC-F80A3454D2AA @default.
• Q37314355 P2860 Q37314355-3761D18B-9F3B-4231-A359-5095228D81BC @default.
• Q37314355 P2860 Q37314355-3E3F7A34-3B1F-49A4-8844-0681056DFC56 @default.
• Q37314355 P2860 Q37314355-3FA79FAE-11D1-4650-83AC-8FDCB1A68BFA @default.
• Q37314355 P2860 Q37314355-442BB981-4269-4EF0-B5A9-EFD5A574F0C4 @default.
• Q37314355 P2860 Q37314355-47E48AD0-5A81-422A-B247-2823548D0ABE @default.
• Q37314355 P2860 Q37314355-48CDFB37-2A86-45E5-8F9C-B2198DBDBE6A @default.
• Q37314355 P2860 Q37314355-56A32380-ACFB-47E8-A4E9-9A7A4279046B @default.
• Q37314355 P2860 Q37314355-6C9909AA-F5CE-46CA-B2CB-B8B0E3EBEE44 @default.
• Q37314355 P2860 Q37314355-6E9ABBD5-AED6-4399-8A7A-CF71FD762E2A @default.
• Q37314355 P2860 Q37314355-6FDC8522-3EE2-420E-A8F9-9407D86CAC28 @default.
• Q37314355 P2860 Q37314355-7060786D-DF38-4DB4-8996-26667564D008 @default.
• Q37314355 P2860 Q37314355-7819A8D4-F035-426C-81BF-EC4C8469BC19 @default.
• Q37314355 P2860 Q37314355-83F94E2A-AC61-4B4D-BCFB-0A454947BFC3 @default.
• Q37314355 P2860 Q37314355-8E27B35E-F801-4D22-B9B8-4F2E1201CF6C @default.
• Q37314355 P2860 Q37314355-A8F5434F-97CC-49D9-ADF8-D188F6A7AE18 @default.
• Q37314355 P2860 Q37314355-A9F6041F-DF60-4D85-A6CE-FD65DAFC01D7 @default.
• Q37314355 P2860 Q37314355-BCA2D0A4-2AE4-457E-9D7B-60A94538C50D @default.
• Q37314355 P2860 Q37314355-C2E18BFA-B228-4561-852D-98113BF381A4 @default.
• Q37314355 P2860 Q37314355-C8C97B3C-B461-41D0-BA37-EB8A0D48FE36 @default.
• Q37314355 P2860 Q37314355-CC358E6F-EA67-424F-8F84-F9C10C7BB112 @default.
• Q37314355 P2860 Q37314355-DA22DB02-EBBA-40CF-A09E-365DC07428A5 @default.
• Q37314355 P2860 Q37314355-DA321B4E-9B4B-4D69-BA24-39155511DB8D @default.
• Q37314355 P2860 Q37314355-DDCD3B60-A53E-419C-A33C-EAF340F56512 @default.
• Q37314355 P2860 Q37314355-E9DDA165-7274-4A4D-AD7F-153FD5D92F7F @default.
• Q37314355 P2860 Q37314355-FBA21C1B-3432-40EE-A2F2-0911AC125904 @default.
• Q37314355 P2860 Q37314355-FDEEFB1F-555B-4C83-AB25-88F4FAC8F1B8 @default.
• Q37314355 P2860 Q37314355-FF064A09-2252-465A-B2ED-531423CC3A73 @default.
• Q37314355 P304 Q37314355-3CF8EED3-6C0E-401A-A35C-B3D3E1821130 @default.
• Q37314355 P31 Q37314355-0780E287-6B59-499F-BA13-3CDFBB6CBF7B @default.
• Q37314355 P356 Q37314355-87752161-0A3F-4DDB-A085-16F494DC181F @default.
• Q37314355 P433 Q37314355-DCF58E9B-081B-4724-A6BF-AD42120695D6 @default.
• Q37314355 P478 Q37314355-AD339249-3477-4281-B12F-3260D6CDBE4D @default.
• Q37314355 P577 Q37314355-8B84E795-081B-478F-80CC-235FF15B2BED @default.
• Q37314355 P5875 Q37314355-3A4DF013-14E3-4C7F-B23D-79DD9043D685 @default.
• Q37314355 P6216 Q37314355-43908cf9-dc83-4d26-8012-2639b828ccf8 @default.
• Q37314355 P698 Q37314355-BAD003BB-B987-4FB5-8931-D6C76FF7ECE8 @default.
• Q37314355 P921 Q37314355-ADA68D3B-C3B9-4991-B742-81AA25A6F302 @default.
• Q37314355 P921 Q37314355-D2A9980A-7C98-4BBC-A817-05745679CEF2 @default.
• Q37314355 P921 Q37314355-FF7EAE53-53BD-4490-BC38-F28220F0DDD0 @default.
• Q37314355 P932 Q37314355-EDD49F15-3AC6-4182-84EB-1388BC6EFC24 @default.
• Q37314355 P356 S10557-013-6476-7 @default.
• Q37314355 P698 23887741 @default.
• Q37314355 P1433 Q2473050 @default.
• Q37314355 P1476 "Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study" @default.
• Q37314355 P2093 "Ana Aldea-Perona" @default.
• Q37314355 P2093 "Antonio Lara-Padrón" @default.
• Q37314355 P2093 "Francisco Marrero-Rodríguez" @default.
• Q37314355 P2093 "Javier López-Díaz" @default.
• Q37314355 P2093 "José Romero-García" @default.
• Q37314355 P2093 "LAICA study investigators" @default.
• Q37314355 P2093 "M del Mar García-Saiz" @default.
• Q37314355 P2093 "Manuel Martínez-Sellés" @default.
• Q37314355 P2093 "Manuel de Mora-Martín" @default.
• Q37314355 P2093 "Marco Cordero" @default.
• Q37314355 P2093 "Martín J García-González" @default.

• next